Latest filing published 28 Jul 2017 for Anaptysbio, INC, €769k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Avalon Ventures VII L P: trading record in brief
Filings by Avalon Ventures VII L P span 2 companies, the busiest being Akesis Pharmaceuticals, Inc. and Anaptysbio, Inc. We count 50 filings; the first trade dates from 8 August 2007 and the latest from 26 July 2017.
The open-market side counts 47 purchases for €1.4M alongside 1 sale for €769k. Purchases outweigh sales by €631k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2017 to date brings no purchases and 1 sale.
Half of the purchases are above €1,806 and half below.
On 28 July 2017 came the latest disclosure, an open-market sale for €769k in Anaptysbio, Inc. The last purchase on record was published on 27 March 2008, which is 6,800 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Avalon Ventures VII L P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,040 shares@ US$24.35100.0% of flowCommon StockSEC:0000899243-17-019280:2
- 399,987 shares0Common StockSEC:0000899243-17-019280:0
- 37,040 shares0Common StockSEC:0000899243-17-019280:1
- 2,352,942 shares@ US$0.85Common StockSEC:0001116679-08-000920:0Canonical exit: 23 Jun 2008 (T+90)
- 5,000 shares@ US$0.46Common StockSEC:0001116679-07-002379:0Canonical exit: 3 Dec 2007 (T+90)
- 5,000 shares@ US$0.47Common StockSEC:0001116679-07-002379:1Canonical exit: 3 Dec 2007 (T+90)
- 5,000 shares@ US$0.48Common StockSEC:0001116679-07-002379:2Canonical exit: 3 Dec 2007 (T+90)
- 5,000 shares@ US$0.47Common StockSEC:0001116679-07-002379:3Canonical exit: 4 Dec 2007 (T+90)
- 5,000 shares@ US$0.49Common StockSEC:0001116679-07-002379:6Canonical exit: 4 Dec 2007 (T+90)
- 5,000 shares@ US$0.47Common StockSEC:0001116679-07-002309:0Canonical exit: 6 Nov 2007 (T+90)
- 10,000 shares@ US$0.48Common StockSEC:0001116679-07-002309:1Canonical exit: 27 Nov 2007 (T+90)
- 5,000 shares@ US$0.51Common StockSEC:0001116679-07-002288:0Canonical exit: 22 Nov 2007 (T+90)
- 5,000 shares@ US$0.51Common StockSEC:0001116679-07-002244:0Canonical exit: 20 Nov 2007 (T+90)
- 5,000 shares@ US$0.50Common StockSEC:0001116679-07-002244:1Canonical exit: 20 Nov 2007 (T+90)
- 15,000 shares@ US$0.50Common StockSEC:0001116679-07-002244:2Canonical exit: 21 Nov 2007 (T+90)
- 5,000 shares@ US$0.50Common StockSEC:0001116679-07-002213:0Canonical exit: 18 Nov 2007 (T+90)
- 5,000 shares@ US$0.51Common StockSEC:0001116679-07-002213:1Canonical exit: 18 Nov 2007 (T+90)
- 10,000 shares@ US$0.56Common StockSEC:0001116679-07-002213:2Canonical exit: 19 Nov 2007 (T+90)
- 10,000 shares@ US$0.54Common StockSEC:0001116679-07-002213:3Canonical exit: 19 Nov 2007 (T+90)
- 35,000 shares@ US$0.50Common StockSEC:0001116679-07-002213:4Canonical exit: 19 Nov 2007 (T+90)
- 10,000 shares@ US$0.48Common StockSEC:0001116679-07-002172:0Canonical exit: 14 Nov 2007 (T+90)
- 10,000 shares@ US$0.47Common StockSEC:0001116679-07-002172:1Canonical exit: 14 Nov 2007 (T+90)
- 5,000 shares@ US$0.46Common StockSEC:0001116679-07-002172:2Canonical exit: 14 Nov 2007 (T+90)
- 10,000 shares@ US$0.45Common StockSEC:0001116679-07-002172:3Canonical exit: 14 Nov 2007 (T+90)
- 5,000 shares@ US$0.47Common StockSEC:0001116679-07-002172:4Canonical exit: 15 Nov 2007 (T+90)
25 of 25 declarations
